• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓瘤中红细胞生成的定量分析。

Quantitation of erythropoiesis in myelomatosis.

作者信息

Birgens H S, Hansen O P, Henriksen J H, Wantzin P

出版信息

Scand J Haematol. 1979 Apr 4;22(4):357-63. doi: 10.1111/j.1600-0609.1979.tb00431.x.

DOI:10.1111/j.1600-0609.1979.tb00431.x
PMID:472659
Abstract

Quantitation of the erythropoiesis with radio-iron (59Fe) was applied to 9 patients with untreated myelomatosis. The method included blocking of the 59Fe reutilization by injection of non-radioactive iron. There was no uniform pattern in the Fe-kinetics values. The Plasma Iron Turnover (PIT) and the Red Blood Cell Iron Turnover (RBCIT) varied from subnormal to values markedly increased above upper normal limit. The calculated average Mean Red Cell Life time (MRCL) of erythrocytes was just below normal range. The mean Marrow Transit Time (MTT) was normal in the patients, despite subnormal venous haematocrit, indicating insufficient stimulation of the bone marrow. The renal function, measured as 51Cr-EDTA clearance, was found positively correlated to the RBCIT (r = 0.78, P less than 0.05). The results suggest that the previously demonstrated relationship between anaemia and renal failure in patients with myelomatosis is caused mainly by an inability of the bone marrow to produce sufficient red blood cells under the stress of anaemia related to the degree of renal impairment.

摘要

用放射性铁(59Fe)对9例未经治疗的骨髓瘤患者进行红细胞生成定量研究。该方法包括通过注射非放射性铁来阻断59Fe的再利用。铁动力学值没有统一模式。血浆铁周转率(PIT)和红细胞铁周转率(RBCIT)从低于正常到明显高于正常上限的值不等。计算得出的红细胞平均平均寿命(MRCL)略低于正常范围。尽管静脉血细胞比容低于正常,但患者的平均骨髓 transit 时间(MTT)正常,表明骨髓刺激不足。以51Cr-EDTA清除率衡量的肾功能与RBCIT呈正相关(r = 0.78,P < 0.05)。结果表明,先前在骨髓瘤患者中证明的贫血与肾衰竭之间的关系主要是由于在与肾功能损害程度相关的贫血应激下,骨髓无法产生足够的红细胞。

相似文献

1
Quantitation of erythropoiesis in myelomatosis.骨髓瘤中红细胞生成的定量分析。
Scand J Haematol. 1979 Apr 4;22(4):357-63. doi: 10.1111/j.1600-0609.1979.tb00431.x.
2
Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe.人体中的铁动力学与红细胞生成:使用59Fe测量有效红细胞生成、无效红细胞生成及红细胞寿命
Br J Haematol. 1975 Sep;31(1):65-75. doi: 10.1111/j.1365-2141.1975.tb00833.x.
3
Ferrokinetics: methods and interpretation.
Clin Nucl Med. 1978 Apr;3(4):159-64. doi: 10.1097/00003072-197804000-00014.
4
Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production.
Br J Haematol. 1992 Dec;82(4):648-53. doi: 10.1111/j.1365-2141.1992.tb06939.x.
5
Studies on erythropoiesis in uremic and post-transplant (renal) patients utilizing radioactive iron and chromium.利用放射性铁和铬对尿毒症患者及移植后(肾脏)患者的红细胞生成进行的研究。
Can Med Assoc J. 1971 Jun 19;104(12):1092-7.
6
Ferrokinetics and erythropoiesis in man: an evaluation of ferrokinetic measurements.人体中的铁动力学与红细胞生成:铁动力学测量的评估
Br J Haematol. 1977 Jan;35(1):41-7. doi: 10.1111/j.1365-2141.1977.tb00561.x.
7
Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
Nephrol Dial Transplant. 1986;1(3):170-4.
8
Quantitation of erythropoiesis by a new method. 3. The blocking effect of inactive iron on radioiron reutilization.
Acta Med Scand. 1974 Apr;195(4):319-23.
9
[Anemia in terminal kidney insufficiency: ferrokinetics, erythrocyte survival times and erythrocyte enzymes in chronic dialysis patients].[终末期肾功能不全患者的贫血:慢性透析患者的铁动力学、红细胞存活时间及红细胞酶]
Nucl Med (Stuttg). 1975 Dec 15;14(4):355-64.
10
Quantitation of erythropoiesis by a new method. I. Studies on healthy subjects.
Scand J Clin Lab Invest. 1966;18(5):493-501. doi: 10.3109/00365516609103911.

引用本文的文献

1
Anaemia in patients with myelomatosis.骨髓瘤患者的贫血
Br J Cancer. 1982 Jun;45(6):887-94. doi: 10.1038/bjc.1982.141.
2
Renal plasma clearance: a valuable marker in myelomatosis.肾血浆清除率:骨髓瘤病中的一个重要指标。
Blut. 1982 Jul;45(1):1-11. doi: 10.1007/BF00320493.